Emyria is a clinical services and drug development company focused on neuroscience and mental health.
Emyria delivers evidence-based and emerging therapies for mental health and other unmet needs across multiple Empax Centres. Emyria gathers ethically sourced real-world data with patients and uses it to improve its therapy and drug development programs.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Emyria's library of unique MDMA-like compounds was developed in partnership with the University of Western Australia for mental health and select neuroscience indications.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.